May. 26 at 1:37 PM
$CNXU : Building Tissue Instead of Replacing It
Conexeu Sciences is a regenerative medicine company developing its proprietary CXU platform to help the body naturally repair and regenerate tissue.
Recent milestones and catalysts:
✅ Commenced trading on Nasdaq under ticker $ CNXU, bringing a newly public regenerative medicine story to the market
✅ Advancing its proprietary CXU platform with a one platform, multiple indications strategy spanning tissue repair, wound care, aesthetics, reconstruction and regenerative applications
✅ Building on more than a decade of research originating from the University of British Columbia and wound healing research programs
CNXU isn’t chasing a single indication. It’s building across markets projected in the tens of billions, including a
$17.8B advanced wound care opportunity and a regenerative medicine market expected to exceed
$22B.
Communicated Disclaimer: https://stockresearchtoday.com/cnxu/
Sector Peers:
$MDXG
$IART
$ARX
